GenSci144 tablet safety study for healthy volunteers
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests the safety of a new tablet called GenSci144 in healthy adults. It helps doctors see if the drug is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26.
- You weigh at least 110 lbs (50 kg) if you're a man, or 99 lbs (45 kg) if you're a woman.
- You are willing to use effective birth control for 3 months after the last dose and not plan pregnancy or donate sperm/eggs.
- You are generally healthy with no major medical conditions like liver, kidney, heart, or stomach problems.
- You do not have a family history of sudden death or serious mental health disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
This is a Phase 1 trial testing a new investigational drug (GSK4771261) in healthy volunteers to understand how the body processes it and to check for safety. Participation involves receiving the study drug and having blood tests and physical exams.
Hear when a new Phenylketonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.